Creating a market for a pharmaceutical

“Disease mongering” is a term coined by some drug-marketing critics to describe what they view as an effort by pharmaceutical companies to enlarge the market for a drug treatment by convincing people that they are suffering from something that can be medically treated.

The pharmaceutical companies can do this either by narrowing the definition of what’s healthy or by expanding the definition of disease—and then creating campaigns to raise awareness of the ostensibly under-diagnosed and under-treated problem.

By promoting a view of a particular condition as widespread, serious, and treatable, these campaigns help to expand markets for a new pharmaceutical product.

Read the article from ATLA

http://www.atla.org/publications/trial/0802/news01.aspx